The Use of Fondaparinux in Preventing Thromboembolism in High Risk Trauma Patients

Clinical trial NCT00531843 · COMPLETED

Trial details

NCT number: NCT00531843
Sponsor: Mary Knudson, M.D.
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Venous Thromboembolism

Start date: 2007-12-01
Primary completion: 2008-06-01
Enrollment: 105

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.